MedCity News
FEBRUARY 17, 2025
Mercks implementation of artificial intelligence in drug research includes analyzing years of existing Merck clinical data to help identify which drugs and drug combinations to pursue. But Merck executive Matt Studney said AI is tool to help, not replace humans. The post Merck Is Embracing AI, But We Always Have a Human in the Loop, Exec Says appeared first on MedCity News.
European Pharmaceutical Review
FEBRUARY 17, 2025
The UK government has announced that the Apprenticeship Levy will be replaced by a new Growth and Skills Levy, a move designed to give employers greater control over workforce training. This change aims to address long-standing concerns that the previous system was too rigid, restricting funding primarily to apprenticeships and limiting investment in other essential training programmes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
FEBRUARY 17, 2025
Memorial Sloan Kettering Cancer Center partnered with AWS to accelerate its research with AI. The collaboration seeks to speed up drug discovery and increase activity within the health systems startup accelerator. The post Memorial Sloan Kettering Teams Up with AWS to Speed Up Drug Discovery appeared first on MedCity News.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction: In 2025, programmatic advertising will continue to redefine how pharmaceutical brands reach healthcare providers (HCPs) and patients. For pharma marketing teams, staying ahead of programmatic advertising trends is not just importantits essential for success. But what trends will shape the future, and how can your team leverage them to drive results?
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
FEBRUARY 17, 2025
Tufts University, Kaiser Permanente and several other healthcare organizations recently launched the Food is Medicine National Network of Excellence. The network aims to develop, assess and share the best practices in the food-is-medicine space. The post What Tufts, Kaiser Permanente and Others Hope to Achieve with the Food is Medicine National Network of Excellence appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
FEBRUARY 17, 2025
AI-generated simulations can standardize diversity in exposure by creating virtual patients from varied backgrounds, each with unique risk factors and life experiences. The post Why Arent More Academic Medical Settings Using Generative AI Avatars to Train Future Doctors on Sensitivity? appeared first on MedCity News.
Pharma Marketing Network
FEBRUARY 17, 2025
Introduction In an era dominated by digital marketing, traditional advertising remains a vital tool for pharma companies to connect with healthcare professionals (HCPs) and patients alike. While online platforms grow, traditional channels such as print ads, TV commercials, and conferences continue to play a crucial role in boosting brand visibility and driving meaningful engagement.
MedCity News
FEBRUARY 17, 2025
Virtual care is no longer just a convenience, it is a necessity. The question is no longer whether virtual-first care is viable but how quickly we can make it the preferred model for modern healthcare. The post ViVE 2025: Shaping the Future of Virtual-first Care appeared first on MedCity News.
PM360
FEBRUARY 17, 2025
Biosector 2 and Novartis Pharmaceutical Corporation More Than Just Words More Than Just Words is a Novartis commitment to help address disparities in breast cancer care for Black women. To assist in bridging communication gaps between Black patients and their HCPs, Novartis partnered with leading multidisciplinary experts including patients, patient advocates, and HCPs to develop and distribute an empathetic learning VR experience to physicians centered around micro moments of implicit bias Blac
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
FEBRUARY 17, 2025
There are now two vaccines to protect against chikungunya approved for use in the US, after Bavarian Nordic gets the green light for Vimkunya.
PM360
FEBRUARY 17, 2025
EVERSANA INTOUCH, Sanofi, and Regeneron Pharmaceuticals, Inc. DUPIXENT Eczema Skin Gallery The DUPIXENT Eczema Skin Gallery tool aims to improve representation for multicultural patients with uncontrolled moderate-to-severe eczema by providing diverse, real patient images to enhance education and inclusivity in dermatological care. By offering a tool where users can self-select skin tones and view eczema across different skin types, the initiative addresses the gap in healthcare imagery for skin
PharmaTimes
FEBRUARY 17, 2025
New test aims to revolutionise prostate cancer screening
PM360
FEBRUARY 17, 2025
The votes have been tallied and the people have spoken. The greatest healthcare and life sciences creatives of 2024, chosen by the people who know this industry best, are unveiled in this issue. We are proud to present your 16th Annual PharmaChoice Award winners. The PharmaChoice awards are quite unlike any other awards in our industry or at PM360 because the winners are picked by the people.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTech
FEBRUARY 17, 2025
Pharmaceutical Technology spoke with Sabine Glden, eLearning & Training Lead at MAIN5, about her experience working in the pharmaceutical industry.
PM360
FEBRUARY 17, 2025
AstraZeneca and Imre Bus Challenge with Austin Dillon To help educate on the realities of and recommendations when dealing with COPD, the BREZTRI brand team turned to brand partner and NASCAR driver, Austin Dillion, whose grandfather lived with COPD, for a game-themed video. The BREZTRI Bus Quiz Challenge takes Austin Dillon and his pit crew on a ride while highlighting important facts about COPD while educating COPD patients about the disease, NASCAR, and Austin Dillon.
PharmaTech
FEBRUARY 17, 2025
Agnes Cwienczek, director of Product Management at ArisGlobal, talks with Pharmaceutical Technology about how careers for women in STEM fields can be nurtured.
PM360
FEBRUARY 17, 2025
DDB Health Changing The Game in EGFR+ mNSCLC RYBREVANT (amivantamab-vmjw) and LAZLCUZE (lazertinib) have distinct and complementary mechanisms of action and their combination has resulted in efficacy that has blown away the long-standing expectation in EGFR+ mNSCLC. The Changing The Game campaign simply yet powerfully showcases how special this combination is by representing it as a fused queen/knight chess piece breaking the norms of an established metaphor to clearly convey unprecedented benef
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
FEBRUARY 17, 2025
GSK joins arch-rival Pfizer in the market for five-in-one meningococcal vaccines with FDA approval for Penmenvy, a top launch prospect for 2025.
PM360
FEBRUARY 17, 2025
Synchrony Healthcare Communications, Inc. and Aurinia Pharmaceuticals LN Know the Signs LN Know the Signs uses creatively adapted road signs to draw attention and deliver its key message with strong stopping power. Designed to drive urgency in diagnosing and managing lupus nephritis (LN), it promotes frequent screening, highlights the severe consequences of untreated LN, and encourages guideline adherence.
PharmaTimes
FEBRUARY 17, 2025
New funding to investigate cognitive decline and brain ageing
PM360
FEBRUARY 17, 2025
Avalere Health and argenx Untold Stories: Life with Myasthenia Gravis Untold Stories: Life with Myasthenia Gravis shares the deeply personal experiences of people living with a rare disease, reaching the listeners who need them most: isolated MG patients and their caregivers, those living with other chronic illnesses, and HCPs in the rare disease space.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaTech
FEBRUARY 17, 2025
The agency has received certification with the Eco-Management and Audit Scheme for its commitment to environmental sustainability.
PM360
FEBRUARY 17, 2025
Biolumina and AstraZeneca Success May Be Fleeting Concurrent chemoradiation therapy (cCRT) can only take patients so far. The Success may be fleeting campaign aims to educate oncologists that the highest risk of progression is within 2 years following cCRT completion and that treatment advances are urgently needed.
Pharmaceutical Technology
FEBRUARY 17, 2025
Two of Bambusas bispecific antibody candidates for immunological and inflammatory disorders are set to enter the clinic in 2025.
PM360
FEBRUARY 17, 2025
EVERSANA INTOUCH and Corcept Therapeutics In the Clutches of Hypercortisolism What if there were something else behind hard-to-control high blood sugar? Meet hypercortisolisma hard-to-spot condition in which excess cortisol raises glucose levels. To help HCPs get better at recognizing and treating hypercortisolism, EVERSANA INTOUCH developed the In the Clutches of Hypercortisolism campaign.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
FEBRUARY 17, 2025
Onos therapy Romvimza is administered twice-weekly compared to Daiichi Sankyos twice-daily Turalio.
PM360
FEBRUARY 17, 2025
Purplemoon and Takeda Oncology Dont Compromise Alunbrig needed a bold and differentiating new campaign to stand out in an increasingly competitive market. As patients with ALK+ NSCLC often need to choose between efficacy and quality of life, we leaned into the iconic lung shape to celebrate the harmony between treatment and life passions and the positive impact being made on patients lives.
PharmaTech
FEBRUARY 17, 2025
The approval makes Evrysdi the first and only tablet for treating spinal muscular atrophy.
Expert insights. Personalized for you.
268 
Let's personalize your content